Case report A 29 year old man attended the accident and emergency department with a three hour history of central chest pain. The pain was described as severe, had no radiation, and was not affected by posture or respiratory effort. The * Volatile hydrocarbon solvents such as toluene. These may be found in lighter fluid, which can be abused by younger patients (<18 years). * Anabolic steroids.'l Myocardial ischaemia due to cocaine can be explained by at least three mechanisms:
(1) The effect on blood constituents by increasing thrombogenicity, enhancing platelet aggregation through adenosine diphosphate, and decreasing fibrinolysis by increasing the concentrations of endogenous inhibitors of tissue plasminogen activator. 5 (2) The sympathomimetic effect causes tachycardia and hypertension. At the same time a mediated vasoconstriction of the coronary artery reduces coronary artery blood flow.
(3) The effect on coronary vessel damage. With chronic use, left ventricular hypertrophy and premature artherosclerosis may develop.6 This feature needs to considered when arranging post-myocardial infarction risk stratification. Chronic abuse is associated with two or three vessel disease and these patients may require coronary angiography to define the extent of coronary vessel damage.
The current recommended management of cocaine induced myocardial ischaemia/ infarction is based on the experience of emergency physicians in the United States, evidence derived from a review of current medical literature, and an understanding of the pathophysiological process.
Management may be divided into two phases. Second phase management should be considered in patients with continuing chest pain or evolving ECG changes. tion dose of 300 mg should achieve this effect, although a logical intervention research regarding the use of aspirin in this specific condition does not exist. * Nitroglycerin: this relieves chest pain in cocaine induced coronary artery spasm. The sublingual route appears to relieve chest pain most rapidly.8 If the intravenous route is chosen the infusion rate is titrated to pain and the systolic blood pressure. PHASE 2 * The use of labetalol is inadvisable. The a adrenergic response is enhanced worsening vasospasm. We should not have used it in this patient and its use may in part explain the difficulty in relieving our patient's pain. Phentolamine blocks the a receptors and may be useful. After the administration of a benzodiazepine it may precipitate hypotension. Low doses (1 mg given in intravenous boluses) are safe.9 The use of f3 blockers in the early management of acute myocardial infarctions has been shown to decrease mortality due to ventricular wall rupture. In cocaine induced myocardial infarction the use of 1B blockers will result in unopposed a receptor stimulation. This will result in an exacerbation of coronary vasoconstriction with an increase of the area of myocardial ischaemia/infarction. We would not advocate its use during the emergency department phase of the management of this condition. * Thrombolysis may be considered in a small number of patients with cocaine induced myocardial infarction. The poor diagnostic specificity (35%) of ECGs and the low mortality of this condition (0-4 %) are arguments against the use of thrombolysis.7 A retrospective cross sectional survey on the safety of thrombolysis in cocaine associated myocardial infarction was undertaken by the Cocaine Associated Myocardial Infarction (CAMI) group; 66 cases were reviewed. Twenty five received thrombolysis while 41 who met electrocardiographic Thrombolysis In Myocardial Infarction (TIMI) criteria did not receive thrombolysis. There were no major complications or deaths in the group that received thrombolysis.'0 Thrombolysis may be considered in patients who: * Have an extension of ST segment elevation. * Have echocardiographic wall motion abnormalities.7 Emergency echocardiograhphy is not readily available in most centres in the UK and the decision will have to be based on the patient's symptoms, evolution of the ECG, and the advice of a cardiologist.
The role of thrombolytic treatment in cocaine associated myocardial infarction is still unclear and larger studies are awaited that may clarify this position.
